PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Headache Unit, Neurology Department, Hospital Universitari Vall d\'Hebron, Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain; Headache and Neurological Pain Research Group, Vall d\'Hebron Research Institute, Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.\', \'Headache and Neurological Pain Research Group, Vall d\'Hebron Research Institute, Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.\', \'Headache Unit, Neurology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.\', \'Headache Unit, Neuroscience Department, Hospital Universitario Virgen Macarena, Sevilla, Spain.\', \'Neurology Department, Hospital Universitario de Gran Canaria Dr. Negrín, Gran Canaria, Spain.\', \'Neurology Department, Hospital Reina Sofia, Tudela, Spain.\', \'Headache Unit, Neurology Department, Hospital Universitario de La Princesa & Instituto de Investigación Sanitaria de La Princesa, Madrid, Spain.\', \'Neurology Department, Clinica Universidad de Navarra, Pamplona, Spain.\', \'Department of Neurology, Institute of Neurosciences, Hospital Clínico San Carlos, IdISSC, Universidad Complutense de Madrid, Madrid, Spain.\', \'Headache Unit, Neurology Department, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain.\', \'Headache Unit, Neurology Department, Hospital Universitari Vall d\'Hebron, Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain; Headache and Neurological Pain Research Group, Vall d\'Hebron Research Institute, Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain. Electronic address: ppozo@vhebron.net.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S2173-5808(21)00160-710.1016/j.nrleng.2021.03.005
?:hasPublicationType
?:journal
  • Neurologia (Barcelona, Spain)
is ?:pmid of
?:pmid
?:pmid
  • 34654536
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Safety of anti-CGRP monoclonal antibodies in patients with migraine during the COVID-19 pandemic: Present and future implications.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34654536>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34654536>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all